# E-DRUG: Re: No Free Lunch (cont'd)

**URL:** <https://talk.edrugplus.org/t/e-drug-re-no-free-lunch-contd/5142>\
**Category:** e-drug\
**Created:** [May 27, 1999, 7:09pm UTC](https://talk.edrugplus.org/t/e-drug-re-no-free-lunch-contd/5142 "1999-05-27T19:09:06Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![joel.lexchin](https://avatars.discourse-cdn.com/v4/letter/j/e9c0ed/32.png) [@joel.lexchin](https://talk.edrugplus.org/u/joel.lexchin)\
**Post date:** [May 27, 1999, 7:09pm UTC](https://talk.edrugplus.org/t/e-drug-re-no-free-lunch-contd/5142/1 "1999-05-27T19:09:06Z")

</div>

E-drug: Re: No Free Lunch (cont'd)  
----------------------------------------------------------

Blaine Carmichael may well be correct when he says that drug products are  
becoming increasingly more sophisticated and that doctors need more  
education about them. The question is what is that best source for that  
education. Studies done over the past 25 years consistently show that the  
more that doctors rely on commercial sources of information, (i.e.,  
information that comes directly from drug companies in the form of ads,  
sales representatives, etc.) the less rational they are as prescribers. I  
don't know of a single study that shows that use of promotional material  
leads to better prescribing. With respect specifically to sales  
representatives there are four studies that rely either on audiotaping of  
interactions between doctors and sales reps (with the sales reps  
permission) or where doctors have filled out surveys immediately after a  
visit. I have done a review of these studies and the basic finding is that  
while the reps usually mention the trade name, generic name and indication  
for the drug they rarely discuss safety issues and when they do it is  
usually in order to put their drug in a good light compared to another  
product. Furthermore, there are frequent inaccuracies in the information  
that reps transmit when compared to the information in objective sources  
such as drug bulletins, textbooks, etc. My article is: Lexchin J. What  
information do physicians receive from pharmaceutical representatives?  
Canadian Family Physician 1997;43:941-5.

If doctors, physician assistants, nurse practitioners want to see sales  
reps they should not expect to get objective information from them.

Joel Lexchin

Joel Lexchin MD  
121 Walmer Rd.  
Toronto, Ontario  
CANADA M5R 2X8  
Phone: (416)-964-7186  
Fax: (416)-923-9515  
e mail: joel.lexchin@utoronto.ca

[Note from moderator: There is also an article in the latest issue of  
Prescrire summarising the French experience: Sales representatives. A  
damning report by Prescrire's reps monitoring network. Prescrire  
International 1999;8(41):86-9 (June 1999) Kirsten Myhr]

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
